Spectrumedix Dissolves, Transgenomic to Maintain Service, Supply Stream | GenomeWeb
NEW YORK (GenomeWeb News) — Spectrumedix, a maker of high-throughput capillary-electrophoresis tools, closed its doors last month, according to Transgenomic, a Spectrumedix distributor.
 
To make up for the resulting supply problems created by the dissolution, which occurred March 9, Transgenomic said it has purchased “certain assets” from the company’s court-appointed receiver along with a license to a gel patent it needs to make consumables for the Spectrumedix systems.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.